Whilst removal of CAR altogether appears to drive a pathological response, we propose that acutely manipulating CAR function, suppressing HDM-induced phosphorylation and stabilising this receptor at the membrane might present a new opportunity to target inflammation in chronic lung disease. This evidence concerns the gene CXADR and chronic lung disease.